Your browser doesn't support javascript.
loading
An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome.
de Vries Schultink, A H M; Alexi, X; van Werkhoven, E; Madlensky, L; Natarajan, L; Flatt, S W; Zwart, W; Linn, S C; Parker, B A; Wu, A H B; Pierce, J P; Huitema, A D R; Beijnen, J H.
Afiliación
  • de Vries Schultink AH; Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. ah.d.vriesschultink@nki.nl.
  • Alexi X; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Werkhoven E; Department of Biometrics, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Madlensky L; Moores Cancer Center, University of California San Diego, San Diego, CA, USA.
  • Natarajan L; Moores Cancer Center, University of California San Diego, San Diego, CA, USA.
  • Flatt SW; Moores Cancer Center, University of California San Diego, San Diego, CA, USA.
  • Zwart W; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Parker BA; Department of Pathology, University Medical Center, Utrecht, The Netherlands.
  • Wu AH; Moores Cancer Center, University of California San Diego, San Diego, CA, USA.
  • Pierce JP; Laboratory Medicine, University of California, San Francisco, CA, USA.
  • Huitema AD; Moores Cancer Center, University of California San Diego, San Diego, CA, USA.
  • Beijnen JH; Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands.
Breast Cancer Res Treat ; 161(3): 567-574, 2017 02.
Article en En | MEDLINE | ID: mdl-28005246
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Antineoplásicos Hormonales / Antagonistas de Estrógenos Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Antineoplásicos Hormonales / Antagonistas de Estrógenos Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos